Literature DB >> 15339287

Estimating the cumulative risk of a false-positive test in a repeated screening program.

Jian-Lun Xu1, Richard M Fagerstrom, Philip C Prorok, Barnett S Kramer.   

Abstract

The goal of screening tests for a chronic disease such as cancer is early detection and treatment with a consequent reduction in mortality from the disease. Screening tests, however, might produce false positive and false-negative results. With an increasing number of screening tests, it is clear that the risk of a false-positive screen, a finding with potentially significant emotional, financial, and health costs, also increases. Elmore et al. (1998, New England Journal of Medicine 338, 1089-1096), Christiansen et al. (2000, Journal of the National Cancer Institute 92, 1657-1666), and Gelfand and Wang (2000, Statistics in Medicine 19, 1865-1879) investigated this problem under the somewhat unrealistic assumption that the choice of making the decision to drop out at the kth screen does not depend upon the results of the earlier k - 1 screens. In this article we obtain sufficient and necessary conditions for their assumption to hold and use one of them to provide a method for testing the validity of the assumption. A new model which does not depend on their assumption is introduced. The maximum likelihood estimator of the cumulative risk of receiving a false-positive screen under the new model is derived and its asymptotic normality is proved. The extension of the new model by incorporating covariate information is also considered. We apply our testing method and the new model to data from the breast cancer screening trial of the Health Insurance Plan of Greater New York.

Entities:  

Mesh:

Year:  2004        PMID: 15339287     DOI: 10.1111/j.0006-341X.2004.00214.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  9 in total

1.  Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.

Authors:  Rebecca A Hubbard; Karla Kerlikowske; Chris I Flowers; Bonnie C Yankaskas; Weiwei Zhu; Diana L Miglioretti
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

2.  Modelling the cumulative risk of a false-positive screening test.

Authors:  Rebecca A Hubbard; Diana L Miglioretti; Robert A Smith
Journal:  Stat Methods Med Res       Date:  2010-03-31       Impact factor: 3.021

3.  Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes.

Authors:  Rebecca A Hubbard; Theodora M Ripping; Jessica Chubak; Mireille J M Broeders; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-31       Impact factor: 4.254

4.  A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring.

Authors:  Rebecca A Hubbard; Diana L Miglioretti
Journal:  Biometrics       Date:  2013-02-05       Impact factor: 2.571

5.  Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Authors:  Dejana Braithwaite; Weiwei Zhu; Rebecca A Hubbard; Ellen S O'Meara; Diana L Miglioretti; Berta Geller; Kim Dittus; Dan Moore; Karen J Wernli; Jeanne Mandelblatt; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2013-02-05       Impact factor: 13.506

6.  Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.

Authors:  Xavier Castells; Eduard Molins; Francesc Macià
Journal:  J Epidemiol Community Health       Date:  2006-04       Impact factor: 3.710

7.  Improving the biomarker pipeline to develop and evaluate cancer screening tests.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2009-07-02       Impact factor: 13.506

8.  Cumulative incidence of false-positive results in repeated, multimodal cancer screening.

Authors:  Jennifer Miller Croswell; Barnett S Kramer; Aimee R Kreimer; Phil C Prorok; Jian-Lun Xu; Stuart G Baker; Richard Fagerstrom; Thomas L Riley; Jonathan D Clapp; Christine D Berg; John K Gohagan; Gerald L Andriole; David Chia; Timothy R Church; E David Crawford; Mona N Fouad; Edward P Gelmann; Lois Lamerato; Douglas J Reding; Robert E Schoen
Journal:  Ann Fam Med       Date:  2009 May-Jun       Impact factor: 5.166

9.  Nonhomogeneous Markov chain for estimating the cumulative risk of multiple false positive screening tests.

Authors:  Marzieh K Golmakani; Rebecca A Hubbard; Diana L Miglioretti
Journal:  Biometrics       Date:  2021-05-18       Impact factor: 1.701

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.